Home > Boards > US Listed > Biotechs >

Abraxis (ABII)

ABII RSS Feed
Add ABII Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 9/27/2010 1:57:29 PM - Followers: 1 - Board type: Free - Posts Today: 0

Abraxis Bioscience, Inc.
11755 Wilshire Boulevard
Suite 2000
90025
United States
 
 
About Abraxis Products Research And Development Patients Abraxis Investor relations and Media Abraxis Careers
Abraxis Logo
Play Video
nab













 

 

 

 

 

 

 

 

 

Abraxis BioScience is a fully integrated biotechnology company dedicated to delivering progressive therapeutics and core technologies that offer patients and medical professionals safer and more effective treatments for cancer and other critical illnesses. The Abraxis portfolio includes the world's first and only protein-based nanoparticle chemotherapeutic compound (ABRAXANE) which is based on its proprietary tumor targeting system known as the nab™ Technology platform. From the discovery and research phase to development and commercialization, Abraxis BioScience is committed to rapidly enriching the company's pipeline and accelerating the delivery of breakthrough therapies that will transform the lives of the patients who need them.

 
 


Click here for Cost Basis Information on the Recent Company separation»


SEC Filings
03/06/09 - Annual 10-K


News Releases

03/03/09 - Abraxis BioScience Reports 2008 Fourth Quarter and Full-Year Financial Results

02/24/09 - Abraxis BioScience Announces Date for 2008 Fourth Quarter and Year-End Financial Results and Investor Conference Call

02/04/08 - Abraxis BioScience Launches ABRAXANE in Germany

01/21/09 - Abraxis BioScience Names Merck Veteran Van der Ploeg to Lead R&D and Drug Development Efforts at Abraxis Health

01/20/09 - Abraxis BioScience Announces Plan to Create Abraxis Health, a New Enterprise Focused on Biomarkers and Personalized Medicine

01/08/09 - Abraxis BioScience to Present at 27th Annual J.P. Morgan Healthcare Conference

View More

 
 

Abraxis Oncology
Abraxis Research
   

Please click here to be directed to APP Pharmaceuticals.

 

 

Abraxis Oncology APP Drugs Press Release Earnings
 
 

 

  • Primary SIC — Industry Classification

    2834 - Pharmaceutical preparations
  • State Of Incorporation

    DE
  • Jurisdiction Of Incorporation

    United States
  • CIK

    0001409012
  • Fiscal Year End

    12/31
  • Estimated Market Cap

    $1,783,238,848 as of Apr 13, 2009
  • Outstanding Shares

    40,063,780 as of Oct 31, 2008
  • Number of Share Holders of Record

    75 as of Mar 31, 2008

www.pinksheets.com/pink/quote/quote.jsp

 

A board to discuss Abraxis

ABII
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PostSubject
#22   6:01PM Abraxis BioScience: Second trial with ABRAXANE to surf1944 05/20/10 07:04:52 PM
#21   8:05AM Abraxis BioScience announces that ABRAXANE meets primary surf1944 03/17/10 10:16:45 AM
#20   Abraxis Bioscien (NASDAQ:ABII) NYBob 02/22/10 11:25:39 PM
#19   8:43AM Abraxis BioScience plans to spin-off Abraxis Health surf1944 01/28/10 09:35:05 AM
#18   Abraxis Bioscien (NASDAQ:ABII) NYBob 01/15/10 02:45:51 AM
#17   Abraxis Bioscien (NASDAQ:ABII) NYBob 11/05/09 10:28:51 AM
#16   8:00AM Abraxis BioScience receives orphan drug status for surf1944 11/05/09 09:10:29 AM
#15   Abraxis Bioscien (NASDAQ:ABII) NYBob 10/20/09 03:21:47 AM
#14   Abraxis Bioscien (NASDAQ:ABII) NYBob 07/27/09 08:31:13 PM
#13   Abraxis Bioscience Inc. (MM) (NASDAQ:ABII) NYBob 06/19/09 12:43:11 AM
#12   Abraxane was approved in the United States* in NYBob 04/14/09 12:35:48 PM
#11   Quick, Powerful, Positive change! - NYBob 04/14/09 11:35:17 AM
#10   Abraxis BioScience (Nasdaq: ABBI) is developing drugs NYBob 04/14/09 11:10:03 AM
#9   Abraxis BioScience Launches ABRAXANE in Germany NYBob 04/14/09 11:04:58 AM
#8   Abraxis BioScience (Nasdaq:ABII) was involved in a separation NYBob 04/14/09 10:56:52 AM
#7   Abraxis BioScience Announces Plan to Create Abraxis Health, NYBob 04/14/09 10:54:07 AM
#6   Abraxis Bioscience Inc. (MM) (ABII) - Level II/Market Depth NYBob 04/14/09 10:50:09 AM
#5   Form 8-K for ABRAXIS BIOSCIENCE, INC. - NYBob 04/14/09 10:48:18 AM
#4   TSC Ratings' Updates: Abraxis BioScience - NYBob 04/14/09 10:47:12 AM
#3   Abraxis Bioscience Inc. NYBob 04/14/09 10:44:54 AM
#2   is there a split coming? interested for sure ronnies 10/29/07 04:31:34 AM
#1   Abraxis MF article (9-26-07). Their improved gfp927z 10/29/07 03:28:08 AM
PostSubject
Consent Preferences